129 related articles for article (PubMed ID: 6141083)
1. Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
Varma TR
Int J Gynaecol Obstet; 1983 Aug; 21(4):291-6. PubMed ID: 6141083
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Varma TR
Acta Obstet Gynecol Scand; 1985; 64(1):41-6. PubMed ID: 2983513
[TBL] [Abstract][Full Text] [Related]
3. Effect of oestrogen and progesterone on fasting serum cholesterol and triglyceride levels in post-menopausal women.
Varma TR; Morsman J
Int J Gynaecol Obstet; 1982 Apr; 20(2):91-7. PubMed ID: 6125443
[No Abstract] [Full Text] [Related]
4. The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women.
Paterson ME; Sturdee DW; Moore B; Whitehead TP
Br J Obstet Gynaecol; 1980 Jul; 87(7):552-60. PubMed ID: 6252948
[TBL] [Abstract][Full Text] [Related]
5. Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
Aedo AR; Sundén M; Landgren BM; Diczfalusy E
Maturitas; 1989 Jun; 11(2):159-68. PubMed ID: 2547139
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of clinical response to piperazine oestrone sulphate ('Harmogen') in menopause patients.
Aylward M; Holly F; Parker RJ
Curr Med Res Opin; 1974; 2(7):417-23. PubMed ID: 4375554
[No Abstract] [Full Text] [Related]
7. Oestrone sulphate in plasma from postmenopausal women and the effects of oestrogen and androgen therapy.
Towobola OA; Crilly RC; Oakey RE
Clin Endocrinol (Oxf); 1980 Nov; 13(5):461-71. PubMed ID: 6261992
[TBL] [Abstract][Full Text] [Related]
8. Effect of orally administered oestrogens on gonadotrophin levels in post-menopausal women.
Aedo AR; Le Donne M; Landgren BM; Diczfalusy E
Maturitas; 1989 Jun; 11(2):147-57. PubMed ID: 2547138
[TBL] [Abstract][Full Text] [Related]
9. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
Cieraad D; Conradt C; Jesinger D; Bakowski M
Arch Gynecol Obstet; 2006 May; 274(2):74-80. PubMed ID: 16491367
[TBL] [Abstract][Full Text] [Related]
10. Coagulation factors in opposed and unopposed oestrogen treatment at the climacteric.
Aylward M
Postgrad Med J; 1978; 54 Suppl 2():31-7. PubMed ID: 740578
[TBL] [Abstract][Full Text] [Related]
11. The effect of low-dose piperazine oestrone sulphate and low-dose levonorgestrel on blood lipid levels in post-menopausal women.
Wren B; Garrett D
Maturitas; 1985 Jul; 7(2):141-6. PubMed ID: 3929024
[TBL] [Abstract][Full Text] [Related]
12. Serum equilin, oestrone, and oestradiol levels in postmenopausal women receiving conjugated equine oestrogens ('Premarin').
Whittaker PG; Morgan MR; Dean PD; Cameron EH; Lind T
Lancet; 1980 Jan; 1(8158):14-6. PubMed ID: 6101354
[TBL] [Abstract][Full Text] [Related]
13. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
Suparto IH; Williams JK; Cline JM; Anthony MS; Fox JL
Am J Obstet Gynecol; 2003 May; 188(5):1132-40. PubMed ID: 12748457
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women.
Aedo AR; Landgren BM; Diczfalusy E
Maturitas; 1990 Nov; 12(4):333-43. PubMed ID: 2124648
[TBL] [Abstract][Full Text] [Related]
15. Conservative treatment of urinary incontinence in women with special reference to the use of oestrogens.
Punnonen R; Kilkku P; Kiukko P; Rauramo L
Maturitas; 1981 Dec; 3(3-4):309-13. PubMed ID: 6278267
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
[TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
[TBL] [Abstract][Full Text] [Related]
18. Estrogen replacement therapy: new options, continuing concerns.
Hanson RM; Melzer DJ
JAMA; 1997 May; 277(19):1515; author reply 1515-7. PubMed ID: 9153359
[No Abstract] [Full Text] [Related]
19. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).
Englund DE; Johansson ED
Br J Obstet Gynaecol; 1978 Dec; 85(12):957-64. PubMed ID: 216384
[TBL] [Abstract][Full Text] [Related]
20. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
